Journal article

p53-dependent and p53-independent anticancer activity of a new indole derivative in human osteosarcoma cells

C Cappadone, C Stefanelli, E Malucelli, M Zini, C Onofrillo, A Locatelli, M Rambaldi, A Sargenti, L Merolle, G Farruggia, A Graziadio, L Montanaro, S Iotti

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | ACADEMIC PRESS INC ELSEVIER SCIENCE | Published : 2015

Abstract

Osteosarcoma (OS) is the most common primary malignant tumor of bone, occurring most frequently in children and adolescents. The mechanism of formation and development of OS have been studied for a long time. Tumor suppressor pathway governed by p53 gene are known to be involved in the pathogenesis of osteosarcoma. Moreover, loss of wild-type p53 activity is thought to be a major predictor of failure to respond to chemotherapy in various human cancers. In previous studies, we described the activity of a new indole derivative, NSC743420, belonging to the tubulin inhibitors family, capable to induce apoptosis and arrest of the cell cycle in the G2/M phase of various cancer cell lines. However,..

View full abstract